Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
LifeMD
13G/A
Amendment 1
LFMD · 53216B104
|
8.4% |
10/7/2026
Event 9/30/2026
|
|||
| Federated Hermes, Inc. | 8.4% | ||||
| Voting Shares Irrevocable Trust | 8.4% | ||||
| Thomas R. Donahue | 8.4% | ||||
| Ann C. Donahue | 8.4% | ||||
| J. Christopher Donahue | 8.4% | ||||
|
EyePoint
13G/A
Amendment 2
EYPT · 30233G209
|
8.0% |
10/7/2026
Event 9/30/2026
|
|||
| Federated Hermes, Inc. | 8.0% | ||||
| Voting Shares Irrevocable Trust | 8.0% | ||||
| Thomas R. Donahue | 8.0% | ||||
| Ann C. Donahue | 8.0% | ||||
| J. Christopher Donahue | 8.0% | ||||
|
aTYR PHARMA INC
13G/A
Amendment 12
ATYR · 002120202
|
5.1% |
10/7/2026
Event 9/30/2026
|
|||
| Federated Hermes, Inc. | 5.1% | ||||
| Voting Shares Irrevocable Trust | 5.1% | ||||
| Thomas R. Donahue | 5.1% | ||||
| Ann C. Donahue | 5.1% | ||||
| J. Christopher Donahue | 5.1% | ||||
|
Arcturus Therapeutics Holdings Inc.
13G/A
Amendment 4
ARCT · 03969T109
|
5.9% |
10/7/2026
Event 9/30/2026
|
|||
| Federated Hermes, Inc. | 5.9% | ||||
| Voting Shares Irrevocable Trust | 5.9% | ||||
| Thomas R. Donahue | 5.9% | ||||
| Ann C. Donahue | 5.9% | ||||
| J. Christopher Donahue | 5.9% | ||||
|
Forte Biosciences, Inc.
13G/A
Amendment 4
FBRX · 34962G208
|
0% |
9/8/2026
Event 8/31/2026
|
|||
| Federated Hermes, Inc. | 0% | ||||
| Voting Shares Irrevocable Trust | 0% | ||||
| Thomas R. Donahue | 0% | ||||
| Ann C. Donahue | 0% | ||||
| J. Christopher Donahue | 0% | ||||
|
Scynexis Inc
13G/A
Amendment 18
SCYX · 811292200
|
4.0% |
7/20/2026
Event 6/30/2026
|
|||
| Federated Hermes, Inc. | 4.0% | ||||
| Voting Shares Irrevocable Trust | 4.0% | ||||
| Thomas R. Donahue | 4.0% | ||||
| Ann C. Donahue | 4.0% | ||||
| J. Christopher Donahue | 4.0% | ||||
|
Scynexis Inc
13G/A
Amendment 17
SCYX · 811292200
|
4.5% |
7/8/2026
Event 6/30/2026
|
|||
| Federated Hermes, Inc. | 4.5% | ||||
| Voting Shares Irrevocable Trust | 4.5% | ||||
| Thomas R. Donahue | 4.5% | ||||
| Ann C. Donahue | 4.5% | ||||
| J. Christopher Donahue | 4.5% | ||||
|
Ovid Therapeutics Inc.
13G/A
Amendment 1
OVID · 690469101
|
4.2% |
7/8/2026
Event 6/30/2026
|
|||
| Federated Hermes, Inc. | 4.2% | ||||
| Voting Shares Irrevocable Trust | 4.2% | ||||
| Thomas R. Donahue | 4.2% | ||||
| Ann C. Donahue | 4.2% | ||||
| J. Christopher Donahue | 4.2% | ||||
|
Minerva Neurosciences, Inc.
13G/A
Amendment 1
NERV · 603380205
|
17.2% |
7/8/2026
Event 6/30/2026
|
|||
| Federated Hermes, Inc. | 17.2% | ||||
| Voting Shares Irrevocable Trust | 17.2% | ||||
| Thomas R. Donahue | 17.2% | ||||
| Ann C. Donahue | 17.2% | ||||
| J. Christopher Donahue | 17.2% | ||||
|
MGP Ingredients, Inc.
13G/A
Amendment 3
MGPI · 55303J106
|
4.6% |
7/8/2026
Event 6/30/2026
|
|||
| Federated Hermes, Inc. | 4.6% | ||||
| Voting Shares Irrevocable Trust | 4.6% | ||||
| Thomas R. Donahue | 4.6% | ||||
| Ann C. Donahue | 4.6% | ||||
| J. Christopher Donahue | 4.6% | ||||
|
LifeMD, Inc.
13G
LFMD · 53216B104
|
5.7% |
7/8/2026
Event 6/30/2026
|
|||
| Federated Hermes, Inc. | 5.7% | ||||
| Voting Shares Irrevocable Trust | 5.7% | ||||
| Thomas R. Donahue | 5.7% | ||||
| Ann C. Donahue | 5.7% | ||||
| J. Christopher Donahue | 5.7% | ||||
|
Forte Biosciences, Inc.
13G/A
Amendment 3
FBRX · 34962G208
|
10.3% |
7/8/2026
Event 6/30/2026
|
|||
| Federated Hermes, Inc. | 10.3% | ||||
| Voting Shares Irrevocable Trust | 10.3% | ||||
| Thomas R. Donahue | 10.3% | ||||
| Ann C. Donahue | 10.3% | ||||
| J. Christopher Donahue | 10.3% | ||||
|
aTYR PHARMA INC
13G/A
Amendment 11
ATYR · 002120202
|
8.7% |
7/8/2026
Event 6/30/2026
|
|||
| Federated Hermes, Inc. | 8.7% | ||||
| Voting Shares Irrevocable Trust | 8.7% | ||||
| Thomas R. Donahue | 8.7% | ||||
| Ann C. Donahue | 8.7% | ||||
| J. Christopher Donahue | 8.7% | ||||
|
Soundthinking, Inc.
13G/A
Amendment 7
SSTI · 82536T107
|
3.5% |
4/7/2026
Event 3/31/2026
|
|||
| Federated Hermes, Inc. | 3.5% | ||||
| Voting Shares Irrevocable Trust | 3.5% | ||||
| Thomas R. Donahue | 3.5% | ||||
| Ann C. Donahue | 3.5% | ||||
| J. Christopher Donahue | 3.5% | ||||
|
Smith Douglas Homes Corp.
13G/A
Amendment 1
SDHC · 83207R107
|
2.9% |
4/7/2026
Event 3/31/2026
|
|||
| Federated Hermes, Inc. | 2.9% | ||||
| Voting Shares Irrevocable Trust | 2.9% | ||||
| Thomas R. Donahue | 2.9% | ||||
| Ann C. Donahue | 2.9% | ||||
| J. Christopher Donahue | 2.9% | ||||
|
MGP Ingredients Inc
13G/A
Amendment 2
MGPI · 55303J106
|
5.6% |
4/7/2026
Event 3/31/2026
|
|||
| Federated Hermes, Inc. | 5.6% | ||||
| Voting Shares Irrevocable Trust | 5.6% | ||||
| Thomas R. Donahue | 5.6% | ||||
| Ann C. Donahue | 5.6% | ||||
| J. Christopher Donahue | 5.6% | ||||
|
Advance Auto Parts Inc
13G
AAP · 00751Y106
|
5.1% |
4/7/2026
Event 3/31/2026
|
|||
| Federated Hermes, Inc. | 5.1% | ||||
| Voting Shares Irrevocable Trust | 5.1% | ||||
| Thomas R. Donahue | 5.1% | ||||
| Ann C. Donahue | 5.1% | ||||
| J. Christopher Donahue | 5.1% | ||||
|
Ttec Holdings, Inc.
13G
TTEC · 89854H102
|
5.2% |
1/8/2026
Event 12/31/2025
|
|||
| Federated Hermes, Inc. | 5.2% | ||||
| Voting Shares Irrevocable Trust | 5.2% | ||||
| Thomas R. Donahue | 5.2% | ||||
| Ann C. Donahue | 5.2% | ||||
| J. Christopher Donahue | 5.2% | ||||
|
Ovid Therapeutics Inc.
13G
OVID · 690469101
|
5.9% |
1/8/2026
Event 12/31/2025
|
|||
| Federated Hermes, Inc. | 5.9% | ||||
| Voting Shares Irrevocable Trust | 5.9% | ||||
| Thomas R. Donahue | 5.9% | ||||
| Ann C. Donahue | 5.9% | ||||
| J. Christopher Donahue | 5.9% | ||||
|
Scynexis, Inc.
13G/A
Amendment 16
SCYX · 811292200
|
8.4% |
1/8/2026
Event 12/31/2025
|
|||
| Federated Hermes, Inc. | 8.4% | ||||
| Voting Shares Irrevocable Trust | 8.4% | ||||
| Thomas R. Donahue | 8.4% | ||||
| Ann C. Donahue | 8.4% | ||||
| J. Christopher Donahue | 8.4% | ||||
|
MGP Ingredients, Inc.
13G/A
Amendment 1
MGPI · 55303J106
|
6.8% |
1/8/2026
Event 12/31/2025
|
|||
| Federated Hermes, Inc. | 6.8% | ||||
| Voting Shares Irrevocable Trust | 6.8% | ||||
| Thomas R. Donahue | 6.8% | ||||
| Ann C. Donahue | 6.8% | ||||
| J. Christopher Donahue | 6.8% | ||||
|
IDEAYA Biosciences, Inc.
13G/A
Amendment 3
IDYA · 45166A102
|
3.9% |
1/8/2026
Event 12/31/2025
|
|||
| Federated Hermes, Inc. | 3.9% | ||||
| Voting Shares Irrevocable Trust | 3.9% | ||||
| Thomas R. Donahue | 3.9% | ||||
| Ann C. Donahue | 3.9% | ||||
| J. Christopher Donahue | 3.9% | ||||
|
Arcturus Therapeutics Holdings Inc.
13G/A
Amendment 3
ARCT · 03969T109
|
11.6% |
1/8/2026
Event 12/31/2025
|
|||
| Federated Hermes, Inc. | 11.6% | ||||
| Voting Shares Irrevocable Trust | 11.6% | ||||
| Thomas R. Donahue | 11.6% | ||||
| Ann C. Donahue | 11.6% | ||||
| J. Christopher Donahue | 11.6% | ||||
|
Minerva Neurosciences, Inc.
13G
NERV · 603380205
|
19.9% |
12/29/2025
Event 12/22/2025
|
|||
| Federated Hermes, Inc. | 19.9% | ||||
| Voting Shares Irrevocable Trust | 19.9% | ||||
| Thomas R. Donahue | 19.9% | ||||
| Ann C. Donahue | 19.9% | ||||
| J. Christopher Donahue | 19.9% | ||||
|
MGP Ingredients Inc
13G
MGPI · 55303J106
|
5.2% |
11/5/2025
Event 10/31/2025
|
|||
| Federated Hermes, Inc. | 5.2% | ||||
| Voting Shares Irrevocable Trust | 5.2% | ||||
| Thomas R. Donahue | 5.2% | ||||
| Ann C. Donahue | 5.2% | ||||
| J. Christopher Donahue | 5.2% | ||||
|
Minerva Neurosciences, Inc.
13D
NERV · 603380205
|
19.3% |
10/28/2025
Event 10/21/2025
|
|||
| Federated Hermes, Inc. | 19.3% | ||||
| Voting Shares Irrevocable Trust | 19.3% | ||||
| Thomas R. Donahue | 19.3% | ||||
| Ann C. Donahue | 19.3% | ||||
| J. Christopher Donahue | 19.3% | ||||
|
Soundthinking, Inc.
13G/A
Amendment 6
SSTI · 82536T107
|
7.8% |
10/7/2025
Event 9/30/2025
|
|||
| Federated Hermes, Inc. | 7.8% | ||||
| Voting Shares Irrevocable Trust | 7.8% | ||||
| Thomas R. Donahue | 7.8% | ||||
| Ann C. Donahue | 7.8% | ||||
| J. Christopher Donahue | 7.8% | ||||
|
Scynexis Inc
13G/A
Amendment 15
SCYX · 811292200
|
11.3% |
10/7/2025
Event 9/30/2025
|
|||
| Federated Hermes, Inc. | 11.3% | ||||
| Voting Shares Irrevocable Trust | 11.3% | ||||
| Thomas R. Donahue | 11.3% | ||||
| Ann C. Donahue | 11.3% | ||||
| J. Christopher Donahue | 11.3% | ||||
|
Forte Biosciences, Inc.
13G/A
Amendment 2
FBRX · 34962G208
|
13.2% |
10/7/2025
Event 9/30/2025
|
|||
| Federated Hermes, Inc. | 13.2% | ||||
| Voting Shares Irrevocable Trust | 13.2% | ||||
| Thomas R. Donahue | 13.2% | ||||
| Ann C. Donahue | 13.2% | ||||
| J. Christopher Donahue | 13.2% | ||||
|
aTYR PHARMA INC
13G/A
Amendment 10
ATYR · 002120202
|
10.8% |
10/7/2025
Event 9/30/2025
|
|||
| Federated Hermes, Inc. | 10.8% | ||||
| Voting Shares Irrevocable Trust | 10.8% | ||||
| Thomas R. Donahue | 10.8% | ||||
| Ann C. Donahue | 10.8% | ||||
| J. Christopher Donahue | 10.8% | ||||
|
Forte Biosciences, Inc.
13G/A
Amendment 1
FBRX · 34962G208
|
11.9% |
9/5/2025
Event 8/31/2025
|
|||
| Federated Hermes, Inc. | 11.9% | ||||
| Voting Shares Irrevocable Trust | 11.9% | ||||
| Thomas R. Donahue | 11.9% | ||||
| Ann C. Donahue | 11.9% | ||||
| J. Christopher Donahue | 11.9% | ||||
|
Forte Biosciences, Inc.
13G
FBRX · 34962G208
|
8.8% |
7/8/2025
Event 6/30/2025
|
|||
| Federated Hermes, Inc. | 8.8% | ||||
| Voting Shares Irrevocable Trust | 8.8% | ||||
| Thomas R. Donahue | 8.8% | ||||
| Ann C. Donahue | 8.8% | ||||
| J. Christopher Donahue | 8.8% | ||||
|
Eyepoint Pharmaceuticals, Inc.
13G/A
Amendment 1
EYPT · 30233G209
|
6.7% |
7/8/2025
Event 6/30/2025
|
|||
| Federated Hermes, Inc. | 6.7% | ||||
| Voting Shares Irrevocable Trust | 6.7% | ||||
| Thomas R. Donahue | 6.7% | ||||
| Ann C. Donahue | 6.7% | ||||
| J. Christopher Donahue | 6.7% | ||||
|
Virgin Galactic Holdings, Inc.
13G/A
Amendment 1
SPCE · 92766K403
|
0.5% |
6/4/2025
Event 5/31/2025
|
|||
| Federated Hermes, Inc. | 0.5% | ||||
| Voting Shares Irrevocable Trust | 0.5% | ||||
| Thomas R. Donahue | 0.5% | ||||
| Ann C. Donahue | 0.5% | ||||
| J. Christopher Donahue | 0.5% | ||||
|
Virgin Galactic Holdings, Inc.
13G
SPCE · 92766K403
|
5.5% |
4/7/2025
Event 3/31/2025
|
|||
| Federated Hermes, Inc. | 5.5% | ||||
| Voting Shares Irrevocable Trust | 5.5% | ||||
| Thomas R. Donahue | 5.5% | ||||
| Ann C. Donahue | 5.5% | ||||
| J. Christopher Donahue | 5.5% | ||||
|
Scynexis, Inc.
13G/A
Amendment 14
SCYX · 811292200
|
15.5% |
1/8/2025
Event 12/31/2024
|
|||
| Federated Hermes, Inc. | 15.5% | ||||
| Voting Shares Irrevocable Trust | 15.5% | ||||
| Thomas R. Donahue | 15.5% | ||||
| Ann C. Donahue | 15.5% | ||||
| J. Christopher Donahue | 15.5% | ||||
|
Atyr Pharma, Inc.
13G/A
Amendment 9
ATYR · 002120202
|
17.5% |
1/8/2025
Event 12/31/2024
|
|||
| Federated Hermes, Inc. | 17.5% | ||||
| Voting Shares Irrevocable Trust | 17.5% | ||||
| Thomas R. Donahue | 17.5% | ||||
| Ann C. Donahue | 17.5% | ||||
| J. Christopher Donahue | 17.5% | ||||